COVID-19 and Cancer: Oncologist Shares His View
Aditya Bardia, MD, MPH, attending physician at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses COVID-19 (Coronavirus) risk in patients with cancer and the elderly.
Aditya Bardia, MD, MPH, attending physician at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses COVID-19 (Coronavirus) risk in patients with cancer and the elderly.
Transcription
We don't have the answers yet in terms of how COVID-19 will impact immunocompromised patients. We do know from what was seen in China that elderly patients were the ones who were at higher risk of having a more serious infection. One can anticipate that immunocompromised patients might also have a more severe form of infection.
Having said that, there's a lot of development that's going on in terms of developing assays to detect this disease earlier. And [there's] also a lot of work being done on vaccines. So there's a lot of work being done which could change the natural history of this disease.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
